This study compares both the feasibility and outcomes of “off-label” transcatheter aortic valve replacement (TAVR) patients (n=156) with a standard “on-label” TAVR population (n=435) at a single institution.
This study compares both the feasibility and outcomes of “off-label” transcatheter aortic valve replacement (TAVR) patients (n=156) with a standard “on-label” TAVR population (n=435) at a single institution.
This study compares both the...